使用32种全因数设计方法,制定和评估一个优化的格利米皮里德透皮治疗系统
Audumbar Mali1, Sunayana Mali2
1Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola-413307, Solapur, Maharashtra, India.
Pharmaceutical nanotechnology
|December 11, 2024
概括
通过皮肤注射的glimepiride贴片为糖尿病治疗提供了一个有希望的替代方案. 优化的配方提供可控的药物释放和改善的皮肤透,克服口服的局限性.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 材料科学 材料科学 材料科学
背景情况:
- 糖尿病影响了大量人口,增加了公共卫生负担.
- 抗糖尿病药物格利梅皮里德具有局限性,包括短半衰期和低生物可用性.
- 通过皮肤递送药物正在探索,以保持格利梅皮里德的均治疗水平.
研究的目的:
- 为了评估含有格利梅皮里德的通过皮肤贴片用于糖尿病治疗.
- 开发一种通过皮肤治疗的方法来克服口服glimepiride的限制.
- 为了实现局部化药物效应和改善患者的服药性.
主要方法:
- 一个3^2的全因数设计被用来优化glimepiride的皮肤贴片.
- 聚乙醇和聚乙烯罗利的度各不相同.
- 实验室释放动力学和数学模型被用来分析药物释放.
主要成果:
- 优化的配方 (F4) 在24小时内释放了96.17%的glimepiride.
- 在最佳配方中观察到零级释放动力学 (r^2=0.987).
- 优化的贴片显示了控制的格利梅皮里德释放,增强的透和沉积.
结论:
- 开发的通过皮肤的glimepiride贴片显示出糖尿病治疗的潜力.
- 数学模型有效地预测了理想的释放和透性特征.
- 这种方法提供了一种可行的替代口服glimepiride治疗方法.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
172
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
172
Factors Influencing Drug Absorption: Pharmaceutical Parameters
119
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
119
Oral Hypoglycemic Agents: Glinides
139
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
139
Insulin Formulations: Types and Delivery
167
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
167
Drug Delivery: Miscellaneous Routes
320
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
320
Drug Delivery: Overview
277
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
277


